{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:06:33Z","timestamp":1780599993637,"version":"3.54.1"},"reference-count":14,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sao Paulo Med. J."],"published-print":{"date-parts":[[2003]]},"abstract":"<jats:p>CONTEXT: Patients with refractory juvenile idiopathic arthritis can benefit from aggressive therapy. CASE REPORT: We followed the clinical course of 4 patients (2 male, 2 female) aged 9.1-17.8 years (mean of 14.5 years) with polyarticular onset of juvenile rheumatoid arthritis and one 16-year-old boy with juvenile spondyloarthropathy associated with inflammatory bowel disease. All the juvenile rheumatoid arthritis patients fulfilled the diagnostic criteria established by the American College of Rheumatology. All patients had unremitting arthritis despite maximum therapy. All patients began receiving treatment using intravenous cyclophosphamide at 500-750 mg\/m\u00b2 and intravenous methylprednisolone at 30 mg\/kg, for 3 days monthly (1 g maximum). The patients received between 3 and 11 monthly treatments, and\/or 3-5 treatments every two months for 12 months, according to the severity of the disease and\/or response to the therapy. All but one patient were evaluated retrospectively at the start (time 0) and 6 months (time 1), and 12 months (time 2) after the beginning of the treatment. A rapid and clinically significant suppression of systemic and articular manifestations was seen in all patients. Our results showed the favorable effect of this treatment on the clinical and some laboratory manifestations of juvenile idiopathic arthritis.<\/jats:p>","DOI":"10.1590\/s1516-31802003000300006","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T10:53:53Z","timestamp":1114599233000},"page":"117-120","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of refractory juvenile idiopathic arthritis via pulse therapy using methylprednisolone and cyclophosphamide"],"prefix":"10.1590","volume":"121","author":[{"given":"Tania Caroline Monteiro de","family":"Castro","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Terreri","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Len","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Odete Esteves","family":"Hil\u00e1rio","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"5","key":"ref1","first-page":"712","article-title":"Criteria for the classification of juvenile rheumatoid arthritis","volume":"23","year":"1972","journal-title":"Bull Rheum Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0007-5248","issn-type":"print"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0733-8635(05)70254-0","article-title":"Management of collagen vascular diseases in childhood","volume":"16","author":"DeSilva TN","year":"1998","journal-title":"Dermatol Clin","ISSN":"https:\/\/id.crossref.org\/issn\/0392-1395","issn-type":"print"},{"issue":"Suppl 10","key":"ref3","first-page":"S97","article-title":"Aggressive treatment in childhood rheumatic diseases","volume":"12","author":"Schaller JG","year":"1994","journal-title":"Clin Exp Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0392-856X","issn-type":"print"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/art.1780360112","article-title":"Aggressive therapy for childhood rheumatic diseases: When are immunosuppressives appropriate?","volume":"36","author":"Lehman TJ","year":"1993","journal-title":"Arthritis Rheum","ISSN":"https:\/\/id.crossref.org\/issn\/0004-3591","issn-type":"print"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0889-857X(05)70362-8","article-title":"Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders","volume":"23","author":"Singsen BH","year":"1997","journal-title":"Rheum Dis Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0889-857X","issn-type":"print"},{"issue":"Suppl 6","key":"ref6","first-page":"15","article-title":"Administration of methylprednisolone pulse in chronic arthritis in children","volume":"9","author":"Job-Deslandre C","year":"1991","journal-title":"Clin Exp Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0392-856X","issn-type":"print"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002281-199805000-00003","article-title":"Update on immunosuppressive therapy","volume":"10","author":"Singer NG","year":"1998","journal-title":"Curr Opin Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/1040-8711","issn-type":"print"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/rheumatology\/37.8.824","article-title":"Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis","volume":"37","author":"Gaffney K","year":"1998","journal-title":"Br J Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0263-7103","issn-type":"print"},{"issue":"2","key":"ref9","first-page":"113","article-title":"Cyclosporin A in paediatric rheumatology","volume":"11","author":"Ansell BM","year":"1993","journal-title":"Clin Exp Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0392-856X","issn-type":"print"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3476(05)80923-0","article-title":"Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis","volume":"120","author":"Graham LD","year":"1992","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/anr.1780320604","article-title":"Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis","volume":"32","author":"Wallace CA","year":"1989","journal-title":"Arthritis Rheum","ISSN":"https:\/\/id.crossref.org\/issn\/0004-3591","issn-type":"print"},{"issue":"9","key":"ref12","first-page":"2036","article-title":"Current treatment by United States and Canadian pediatric rheumatologists","volume":"26","author":"Cron RQ","year":"1999","journal-title":"J Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0315-162X","issn-type":"print"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780401019","article-title":"Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis","volume":"40","author":"Wallace CA","year":"1997","journal-title":"Arthritis Rheum","ISSN":"https:\/\/id.crossref.org\/issn\/0004-3591","issn-type":"print"},{"issue":"4","key":"ref14","first-page":"612","article-title":"Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis preliminary results of a longterm study","volume":"19","author":"Shaikov AV","year":"1992","journal-title":"J Rheumatol","ISSN":"https:\/\/id.crossref.org\/issn\/0315-162X","issn-type":"print"}],"container-title":["Sao Paulo Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/spmj\/v121n3\/16713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T19:17:49Z","timestamp":1495653469000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-31802003000300006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003]]}},"alternative-id":["S1516-31802003000300006"],"URL":"https:\/\/doi.org\/10.1590\/s1516-31802003000300006","relation":{},"ISSN":["1516-3180"],"issn-type":[{"value":"1516-3180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003]]}}}